Bloomberg Businessweek (Europe)
Next Steps
The U.S. Food and Drug Administration cleared Pantheris for PAD treatment in October. Simpson says Avinger is working to make the device smaller and softer so it can also be used to treat the especially delicate coronary arteries. “Pantheris is a major upgrade,” says Thomas Davis, a doctor treating cardiovascular disease at St. John Hospital & Medical Center in Detroit. He calls it “a game changer for patient care.”